300653.SZ
正海生物
SZSE · Healthcare · C 制造业 · CN
CNY 14.78
−1.92%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 40.99x
- P/E 2027E
- 38.86x
- P/E 2028E
- 34.00x
- P/S forward
- 7.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- 32.28x
- PEG TTM
- —
- Price / book
- 3.11x
- Price / sales
- 7.74x
- Price / cash flow
- 37.92x
Enterprise value
- Enterprise value
- CNY 2.6B
- EV / sales
- 7.58x
- EV / EBITDA
- 23.53x
- EV / EBIT
- 35.05x
- Market cap
- CNY 2.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026